What Happened
China’s population aged 60 and above has surpassed 323 million — an increase of more than 100 million in a single decade — according to official data released August 1, 2026. Here’s what it means for your China business.
Why It Matters
China is aging faster than any major economy in history. The country added roughly 10 million seniors per year over the past decade, and the 60+ cohort now represents approximately 23% of the total population. By 2035, that figure is projected to reach 30% — roughly 420 million people.
For foreign companies in healthcare, medical devices, pharmaceuticals, insurance, and senior living, this is not just a demographic headline. It is a market-size signal. China’s “silver economy” (银发经济, yínfà jīngjì) was valued at approximately 7 trillion yuan (US$960 billion) in 2025 and is on track to exceed 10 trillion yuan by 2028, according to a State Council white paper published in early 2026.
The pressure on China’s public pension system is intensifying. Eleven of China’s 31 provincial-level regions already run pension deficits, subsidized by central government transfers. This fiscal reality is forcing policy acceleration — opening doors for private-sector and foreign participation in areas previously dominated by state-owned enterprises.
The Details
The new data, published by the National Bureau of Statistics (NBS) and the Ministry of Civil Affairs, reveals a structural challenge that Beijing can no longer manage entirely through public spending. Three policy shifts are already underway:
1. Foreign investment in eldercare is being liberalized. Under the 2026 Special Administrative Measures (Negative List), the eldercare sector was moved from “restricted” to “encouraged” for foreign investment. Foreign-invested eldercare institutions in pilot zones such as Shanghai, Guangzhou, and Chengdu can now operate with the same registration process as domestic entities. The removal of the joint-venture requirement means wholly foreign-owned eldercare facilities (WFOE) are now permitted in these cities.
2. Medical device and pharmaceutical registration is accelerating. The National Medical Products Administration (NMPA) fast-tracked 47 foreign medical devices for elderly care in the first half of 2026 — a 35% increase from the same period in 2025. Products related to mobility assistance, remote patient monitoring, and age-related chronic disease management received priority review status averaging 98 working days, down from 145 days in 2024.
3. Private insurance pilots are expanding. The National Financial Regulatory Administration (NFRA) approved five new pilot cities in July 2026 for foreign insurers to offer long-term care insurance products — a market that Chinese regulators estimate will require 1.5 trillion yuan in annual premium volume by 2030. Allianz and AXA have already launched products in the first pilot batch, with Prudential and Generali expected to enter in Q4 2026.
The scale of the opportunity is enormous but the operational friction is real. China has roughly 8.2 million eldercare beds but needs an estimated 20 million by 2030. There are fewer than 300,000 certified geriatric care professionals in a country that needs over 1 million. Foreign operators who can bring training protocols, care standards, and technology — not just capital — will have the strongest negotiating position with local governments.
What You Should Do
If your business operates in or is considering entering China’s healthcare, insurance, or senior-living sectors, here is your checklist for the next 90 days:
- Reassess your Negative List status. If you previously ruled out China because eldercare was restricted, revisit the 2026 Negative List. The “encouraged” designation unlocks preferential tax treatment, simplified foreign exchange procedures, and land-use subsidies in many cities.
- Map the pilot cities. Focus on Shanghai, Guangzhou, Chengdu, Hangzhou, and Nanjing — the five cities with the most mature foreign eldercare pilots and the highest concentration of high-net-worth seniors who can pay out-of-pocket for premium services.
- Partner with a domestic hospital group. Pure real-estate senior living has thin margins in China. The most successful foreign models integrate clinical services. Tie your market entry to a partnership with a domestic hospital network — this unlocks NMPA fast-track eligibility and local government support.
- Watch the insurance regulator. The NFRA’s long-term care insurance pilot expansions are announced quarterly. The next batch is expected in October 2026. If you are an insurer, get your product application ready now — slot allocations are competitive.
One Data Point
The number to remember: 323 million. China’s 60+ population is larger than the entire population of the United States. Within five years, one in four Chinese citizens will be over 60. No global healthcare or eldercare strategy is complete without a China component.
Where to Go From Here
Based on what you just read:
- Ready to act? Read China 2026 Investment Policy Blitz: Negative List Shortened, R&D Tax Extended
- Still comparing? See China Carbon Market Expansion 2026: What Foreign Companies Must Prepare Now
- Need numbers? Try How Global GLP-1 Drug Demand Is Fueling China’s Pharma CDMO Boom: 2026 Update
— China Gateway 360 —
Remote China market entry support, built around execution.
